Methods of decreasing or preventing pain using spicamycin...

Details Methods of decreasing or preventing pain using spicamycin... Methods of decreasing or preventing pain using spicamycin...

2007-03-27

2007-03-27

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S046000, C536S027600

Reexamination Certificate

active

10380354

ABSTRACT:
Methods of providing pain relief by administering a water-soluble derivative of spicamycin. Methods of using pain mediation agents are also provided.

REFERENCES:
patent: 5252463 (1993-10-01), Nelson et al.
patent: 5905069 (1999-05-01), Borsook et al.
patent: 6087091 (2000-07-01), Justice et al.
patent: 0525479 (1993-02-01), None
Vilassova N. et al., “The Effects of KRN5500, a Spicamycin derivative, on Neuropathic and Nociceptive Pain Models in Rats.”,Database PubMed, US National Library of Medicine, No. 11004056, Abstract; 2000.
Supplementary European Search Report for EP01971222 mailed Sep. 12, 2005.
Kamishohara et al., “Antitumor activity of a spicamycin derivative, KRN5500, and its active metabolite in tumor cells,” Oncol Res 1994; 6:383-90.

Affiliated with

Also associated with

Rating

Methods of decreasing or preventing pain using spicamycin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of decreasing or preventing pain using spicamycin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of decreasing or preventing pain using spicamycin... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3802226